RI
Repositioning IntelligenceResearch Intelligence · Not for Patient Care
Back to overview

Disease-centric intelligence

Navigate disease signatures with verified repositioning evidence.

Each disease workspace links to candidate drugs with graded evidence from PubMed, clinical trials, and regulatory sources.

Type 2 Diabetes MellitusICD-10 E11
No evidence

Chronic metabolic disorder characterized by insulin resistance and progressive β-cell dysfunction.

Evidence pipeline pending
Open disease workspaceLaunch →
Breast CancerICD-10 C50
Moderate Evidence

Malignant neoplasm of breast tissue with heterogeneous molecular subtypes.

1 evidence record
Open disease workspaceLaunch →
Pulmonary Arterial HypertensionICD-10 I27.0
Approved

Progressive narrowing of pulmonary arterioles leading to right heart failure.

1 evidence record
Open disease workspaceLaunch →
Multiple MyelomaICD-10 C90.0
Approved

Plasma cell malignancy characterized by bone lesions, anemia, and renal impairment.

1 evidence record
Open disease workspaceLaunch →
COVID-19ICD-10 U07.1
Strong Repurposing Signal

Acute respiratory disease caused by SARS-CoV-2 with variable severity and systemic inflammation.

2 evidence records
Open disease workspaceLaunch →
Tuberous Sclerosis ComplexICD-10 Q85.1
Approved

Autosomal dominant disorder with hamartomas in multiple organs due to mTOR pathway dysregulation.

1 evidence record
Open disease workspaceLaunch →
HypothyroidismICD-10 E03.9
Approved

Deficiency of thyroid hormone causing metabolic slowing, fatigue, and systemic symptoms.

1 evidence record
Open disease workspaceLaunch →
Cardiovascular DiseaseICD-10 I25.9
Approved

Spectrum of atherosclerotic and thrombotic conditions affecting heart and vasculature.

1 evidence record
Open disease workspaceLaunch →
Benign Prostatic HyperplasiaICD-10 N40
Approved

Non-malignant prostate enlargement causing lower urinary tract symptoms.

1 evidence record
Open disease workspaceLaunch →
Androgenetic AlopeciaICD-10 L64
Approved

Pattern hair loss driven by androgen sensitivity and follicular miniaturization.

1 evidence record
Open disease workspaceLaunch →
Rheumatoid ArthritisICD-10 M06.9
No evidence

Autoimmune inflammatory arthritis with symmetric joint involvement and systemic features.

Evidence pipeline pending
Open disease workspaceLaunch →
Polycystic Ovary SyndromeICD-10 E28.2
No evidence

Endocrine disorder with hyperandrogenism, ovulatory dysfunction, and metabolic features.

Evidence pipeline pending
Open disease workspaceLaunch →
HypertensionICD-10 I10
No evidence

Persistently elevated arterial blood pressure.

Evidence pipeline pending
Open disease workspaceLaunch →
Erectile DysfunctionICD-10 N52.9
No evidence

Inability to achieve or maintain erection sufficient for intercourse.

Evidence pipeline pending
Open disease workspaceLaunch →